Skip to main content
. 2017 Feb 7;13(4):1526–1534. doi: 10.3892/etm.2017.4103

Table III.

Therapeutic evaluation, complications and follow-up data of argatroban treatment.

Patient Surgery in-hospital Clinical outcome Thrombolysis degree Complications Follow-up duration (months) Outcome of follow-up
  1 N/A Elimination of symptoms Partial N/A 18 Surgical treatment for jejunum perforation, but no recurrence
  2 N/A Clinical improvement Partial N/A 18 No recurrence
  3 N/A Clinical improvement Partial N/A 15 No recurrence
  4 N/A Elimination of symptoms None Hematochezia 18 Recurrence
  5 N/A Elimination of symptoms Partial N/A 14 No recurrence
  6 N/A Clinical improvement Partial N/A 15 No recurrence
  7 N/A Elimination of symptoms Partial N/A 12 No recurrence
  8 Resection of 130 cm of the small bowel Clinical improvement Partial N/A 12 No recurrence
  9 N/A Clinical improvement Partial N/A 12 No recurrence
10 N/A Clinical improvement Partial N/A 15 No recurrence
11 N/A Clinical improvement Complete N/A 24 No recurrence
12 N/A No improvement None Hematochezia   6 Recurrence and mortality
13 Resection of 90 cm of the jejunum Clinical improvement Partial N/A 20 No recurrence
14 N/A Clinical improvement Partial N/A 20 No recurrence
15 N/A Elimination of symptoms Partial N/A 20 No recurrence
16 N/A Elimination of symptoms Partial N/A 18 No recurrence
17 N/A Clinical improvement Partial N/A 15 Surgical treatment for intestinal obstruction, but no recurrence
18 N/A Clinical improvement Partial N/A 20 No recurrence

The serial numbers of the patients are the same as those used in Table II. N/A, not applicable.